AI biotech startup Enveda doubles in value to $2 billion - WSJ
Source link: Note: Reuters has not verified this story and does not vouch for its accuracy
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Source link: Note: Reuters has not verified this story and does not vouch for its accuracy
By Xavier MartinezEnveda, a privately held AI biotechnology startup, has doubled its valuation to about $2 billion as momentum builds behind tech-driven approaches to discovering new medicines.The financing will help the Boulder, Colo.-based company fund later-stage human trials. Healthcare investo…